Deaths raise concerns over selling plasma in Canada
The practice of selling plasma in Canada is under scrutiny following the deaths of two donors. Concerns about the safety of paid plasma donation have been raised, prompting criticism of the current regulations. The article discusses the process of plasma collection and the implications for donors and patients alike.
- ▪Two plasma donors have died, raising safety concerns about paid plasma donation in Canada.
- ▪Plasma is used to create medicines for individuals with immunodeficiencies.
- ▪The article features insights from a healthcare reporter on the regulation of plasma collection.
The Globe and Mail publishes from Canada and files mainly under world. We currently carry 1,935 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | The Globe and Mail |
| Canonical URL | https://www.theglobeandmail.com/podcasts/the-decibel/article-deaths-raise-concerns-over-selling-plasma-in-canada/ |
| Publication time | Mon, 25 May 2026 09:00:00 +0000 |
| Retrieval time | 2026-05-25T09:07:36.534Z |
| Last seen | 2026-05-25T09:07:36.534Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | oMvHgOLiI4F8 |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Open this photo in gallery:Plasma is collected from a donor into a collection bag at a Canadian Blood Services location in Scarborough, April 16, 2026.EDUARDO LIMA/The Globe and MailShareSave for laterPlease log in to bookmark this story.Log InCreate Free AccountListen to this episode by clicking above or subscribe to The Decibel on your favourite podcast app or platform: Apple Podcasts, Spotify, Amazon Music, iHeartRadio, Pocket Casts and YouTube.Getting paid for plasma – the yellow-gold liquid part of blood – in Canada is still pretty new. It’s full of protein and antibodies and can be used to make medicine for immunodefficient people. But following the deaths of two plasma donors, the practice is facing criticism and concerns are being raised about its safety.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Globe and Mail.
Discussion
0 commentsMore from The Globe and Mail
